Corrigendum to “Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway”

Joint Authors

Lu, Guotao
Wu, Dacheng
Wu, Keyan
Gong, Weijuan
Ding, Yanbing
Xiao, Weiming
Zhu, Qingtian
Shan, Qing
Yan, Zhigang
Wu, Jian
Deng, Bin
Xue, Yan

Source

Mediators of Inflammation

Issue

Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-3, 3 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2018-09-06

Country of Publication

Egypt

No. of Pages

3

Main Subjects

Diseases

Abstract EN

In the article titled “Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway” [1], the protein labels in Figures 6(h) and 6(i) were reversed and should be corrected as follows:

American Psychological Association (APA)

Wu, Dacheng& Wu, Keyan& Zhu, Qingtian& Xiao, Weiming& Shan, Qing& Yan, Zhigang…[et al.]. 2018. Corrigendum to “Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway”. Mediators of Inflammation،Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1204530

Modern Language Association (MLA)

Wu, Dacheng…[et al.]. Corrigendum to “Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway”. Mediators of Inflammation No. 2018 (2018), pp.1-3.
https://search.emarefa.net/detail/BIM-1204530

American Medical Association (AMA)

Wu, Dacheng& Wu, Keyan& Zhu, Qingtian& Xiao, Weiming& Shan, Qing& Yan, Zhigang…[et al.]. Corrigendum to “Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway”. Mediators of Inflammation. 2018. Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1204530

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1204530